InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines HST Q1 2026 Earnings Strong EPS Beat Surprises Markets CVR Energy Q1 2026 Earnings Substantial EPS Miss Amid Challenging Refining Environment DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending DouYu Q4 2025 Earnings Massive EPS Beat Yet Stock Declines Amid Revenue Uncertainty NTGR Q1 2026 Earnings EPS Returns to Profitability with 268 Surprise